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The skin is a unique organ that contains two differ-
ent subsets of dendritic cells, i.e., Langerhans cells
and dermal dendritic cells. Our hypothesis is that
cutaneous ®broblasts may affect the development of
these dendritic cells. We cocultured cord blood
CD34+ hematopoietic progenitor cells with several
human cutaneous ®broblast cell lines without any
exogenous cytokines for 3 wk. In this culture, hema-
topoietic progenitor cells increased in number from
20.1 6 2.4 times, and produced aggregates of cells
with dendritic processes. They were composed of
54.9 6 3.2% HLA-DR+ CD14+ CD1a± cells and
13.8 6 3.6% HLA-DR+ CD1a+ cells, which also
expressed CD11b and CD11c. There were signi®cant
numbers of factor XIIIa+ cells in the culture, whereas
no Lag+ or E-cadherin+ cells were detected, and they
were potent stimulators in allogeneic T cell acti-
vation. There was a signi®cant difference in the abil-
ity to induce CD1a+ cells among different human
cutaneous ®broblast cell lines. These CD1a+ cells
lacked the expression of CD80, CD86, or CD83. In
addition, half of them still expressed CD14. When
these dendritic cells were cultured with tumor necro-
sis factor-a, however, they became mature dendritic
cells with augmented expression of CD86 and CD83
and with increased allogeneic T cell stimulation. The
subsequent experiment using a dividing chamber,
enzyme-linked immunosorbent assay for granulo-
cyte-macrophage colony-stimulating factor and
macrophage colony-stimulating factor, and the
blocking studies with antibodies for these cytokines
suggested that both the presence of direct contact
between hematopoietic progenitor cells and human
cutaneous ®broblast cell lines and macrophage
colony-stimulating factor produced by human cuta-
neous ®broblast cell lines are required for their max-
imum growth and differentiation into CD1a+
dendritic cells, whereas macrophage colony-stimulat-
ing factor was solely responsible for their differenti-
ation. These data suggest that cutaneous ®broblasts
support the differentiation of dermal dendritic cells
in addition to that of monocytes from hematopoietic
progenitor cells by their direct contact with hemato-
poietic progenitor cells and by their macrophage
colony-stimulating factor production. Key words:
cadherin/factor XIIIa/granulocyte-macrophage colony-
stimulating factor/Langerhans cells. J Invest Dermatol
118:450±460, 2002
R
ecent progress in the ®eld of cytokine-derived
dendritic cell (DC) growth and differentiation has
elucidated that different combinations of hemato-
poietic growth factors, such as granulocyte-macro-
phage colony-stimulating factors (GM-CSF),
interleukin (IL)-3, tumor necrosis factor (TNF)-a, stem cell factor,
Flt3 ligand (Flt3L), and transforming growth factor (TGF)-b, can
generate DC in vitro from bone marrow, cord blood, or adult blood
CD34+ hematopoietic progenitor cells (HPC). (Caux et al, 1992,
1996a, b; Reid et al, 1992; Santiago-Schwarz et al, 1992; Romani et
al, 1994; Bernhard et al, 1995; Siena et al, 1995; Szabolcs et al, 1995,
1996; Herbst et al, 1996; Rosenzwajg et al, 1996; Strobl et al, 1996;
Strunk et al, 1996). In addition, these studies have increased our
knowledge about the subsets of DC. DC comprise at least three
distinct subsets, including two with a myeloid lineage and a third
represented by lymphoid DC. Langerhans cells and interstitial DC
constitute two types of immature myeloid DC in vivo. In in vitro
cultures of CD34+ HPC in GM-CSF/TNF-a-supplemented
medium, CD14± CD1a+ Langerhans cell precursors and
CD14+ CD1a± precursors, which apparently differ from each
other in their lineage commitment, emerge early during the
culture. Langerhans cells precursors give rise to CD1a+ E-cadherin
(E-cad)+ Birbeck granule (BG)+ but CD11b± CD36± factor XIIIa
(FXIIIa)± Langerhans cells, whereas CD14+ CD1a± precursors
differentiate into macrophage/monocyte and non-Langerhans cell
interstitial DC with the help of M-CSF and GM-CSF/TNF-a,
respectively (Caux et al, 1992; Strunk et al, 1996). These interstitial
DC, which are characterized by the abundant expression of FXIIIa,
CD1a, CD11b, and CD36 with the virtual absence of E-cad and
BG, display striking similarities to dermal DC (Nestle et al, 1993;
Caux et al, 1996a, 1997; de Saint-Vis et al, 1998).
In spite of these observations, however, we have not been able to
identify which cytokines really function in these processes and what
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kinds of cells produce these relevant cytokines in the differentiation
of DC from HPC in vivo. Recently, Miralles et al (1998) have
reported that human thymic stromal cells induce both the
proliferation of CD34+ HPC and their differentiation into DC
in vitro without cytokines or serum supplementation.
Skin is a unique organ that contains two different subsets of DC,
i.e., Langerhans cells in the epidermis and non-Langerhans cell
dermal DC in the dermis. Therefore, our hypothesis is that
cutaneous ®broblasts may affect the development of these DC. For
this purpose, it is reasonable to examine the effects of dermal
®broblasts on the precursors of DC in the peripheral blood.
Recently, Ito et al (1999) have identi®ed the direct precursors of
epidermal Langerhans cells in the peripheral blood as
CD1a+ CD11c+ populations. In contrast, the precursors of dermal
DC still remain unknown. Thus, in this study, we examined the
effects of cutaneous ®broblasts on CD34+ HPC instead of
examining those on the direct precursors in the peripheral blood.
Here we report that several cutaneous ®broblast cell lines (CFCL)
could de®nitely support the proliferation of CD34+ HPC and their
differentiation into DC, especially CD1a+ E-cad± BG± FXIIIa+
CD11b+ CD11c+ non-Langerhans cell DC, without any exo-
genous cytokines. These DC had immature phenotypes, such as the
lack of CD80, CD83, or CD86 expression, however, although they
were potent antigen-presenting cells in the allogeneic T cell
stimulation. They were further maturated with lipopolysaccharide
(LPS) or TNF-a. The subsequent experiments to examine the
mechanism for the effects of ®broblasts demonstrated that direct
contact of CD34+ HPC with CFCL or M-CSF produced by
CFCL was responsible for the optimal proliferation and differen-
tiation of CD34+ HPC into CD1a+ E-cad± BG± FXIIIa+ CD11b+
CD11c+ non-Langerhans cell DC.
MATERIALS AND METHODS
Media and reagents The medium used in the study was RPMI-1640
including 25 mM Hepes buffer (Sigma, St Louis, MO) supplemented
with 2 mM L-glutamine, 1 mM sodium pyruvate, 50 mM 2-
mercaptoethanol, 1% penicillin, streptomycin, and fungizone antibiotic
solution (Sigma), and 10% fetal calf serum (Bio West, Nuaille, France)
(complete medium). The buffer used for the puri®cation of CD34+
HPC from the cord blood was phosphate-buffered saline supplemented
with 1% bovine serum albumin (less than 1 ng per mg of detectable
endotoxin) (Sigma) and 5 mM ethylenediamine tetraacetic acid (MACS
buffer).
We used the following monoclonal antibodies for immunostaining:
¯uorescein isothiocyanate (FITC)-conjugated anti-CD3 antibody, FITC-
conjugated anti-CD14 antibody, phycoerythrin (PE)-conjugated anti-
CD11b antibody, PE-conjugated anti-CD19 antibody (Dakopatts,
Glostrup, Denmark), FITC-conjugated anti-CD86 antibody, PE-conju-
gated anti-CD16 antibody, PE-conjugated anti-CD56 antibody
Figure 1. The coculture with cutaneous ®broblast cell lines supports the growth of CD34+ hematopoietic stem cells and their
differentiation into DC. Three ml of NDF-1, NDF-2, CF-1, CF-2 or CF-3 (1 3 105 cells per ml) were seeded in 60 3 15 mm style Petri dishes.
When these cells became con¯uent, they were irradiated with 2000 rad. Afterwards, 3 3 104 cells per ml of cord blood CD34+ HPC were added into
these ®broblast cultures. Cultures were kept at 37°C in a 5% CO2 humidi®ed condition. Cells were recovered at 21±28 d of culture for analysis. As a
control, CD34+ HPC were cultured with GM-CSF, TNF-a, and Flt3L. (a) The culture of CD34+ HPC without ®broblasts. (b) The coculture of
CD34+ HPC with CF-2 (day 14). (c) The proliferating cells from the coculture of CD34+ HPC with CF-2 were harvested by gentle pipetting (day 20)
and further cultured for 2 d without ®broblasts. (d) The proliferation of CD34+ HPC cultured in the upper chamber of a dividing chamber (day 20).
(e) TNF-a stimulates DC derived from the coculture of CD34+ HPC with CF-2 to form cell aggregates. (f ) TGF-b1 does not signi®cantly alter the
morphology of DC derived from the coculture of CD34+ HPC with CF-2. (g)The culture of CD34+ HPC with GM-CSF, TNF-a, and Flt3L
(day 13).
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(PharMingen, San Diego, CA), FITC-conjugated anti-CD45 antibody,
PE-conjugated anti-CD80 antibody, FITC-conjugated anti-HLA-DR
antibody (Becton-Dickinson, San Jose, CA), FITC-conjugated or PE-
conjugated anti-CD1a antibody, PE-conjugated anti-CD11c antibody,
PE-conjugated CD83 antibody (Coulter, Hialeah, FL), FITC or PE-
conjugated isotype-matched mouse control antibodies (IgG1 and IgG2a
from PharMingen, and IgG2b from Ancell, Bayport, MN), monoclonal
anti-human E-cad antibody (Takara Biomedicals, Tokyo, Japan), anti-
BG-associated antigen antibody, Lag (gift of Dr F. Furukawa,
Hamamatsu University, Sizuoka, Japan), and isotype control antibody
(IgG1) (Sigma). We also used rabbit anti-human FXIIIa antibody
(Berhingerwerke, Marburg, Germany; 1:800 dilution in ®nal concentra-
tion) and rabbit anti-FVIII antibody (Dakopatts; 1:800 dilution) as a
negative control. Recombinant human GM-CSF was a gift from Kirin
Brewery (Tokyo, Japan) and recombinant human TNF-a, recombinant
human M-CSF, recombinant human TGF-b1, and recombinant human
Flt3L were purchased from PepreoTech EC (London, U.K.).
Isolation of CD34+ HPC Umbilical cord blood samples were
obtained according to the institutional guidelines. Cells bearing CD34
antigen were isolated from mononuclear fractions through positive
selection as described (Gatti et al, 2000). Brie¯y, mononuclear cells were
prepared by discontinuous density gradient centrifugation using
Lymphoprep (Nycomed Pharma As, Oslo, Norway). CD34+ HPC were
isolated from these mononuclear cells, using a Direct CD34 Progenitor
Cell Isolation Kit (Miltenyi Biotec GmBH, Bergisch Gladbach,
Germany) and MiniMACS separation columns (Miltenyi Biotec)
according to the manufacturer's protocol.
CFCL We used ®ve human CFCL. Two different lots of human
neonatal dermal ®broblasts (NDF-1 and NDF-2) were obtained from
Kurabo Industries (Tokyo, Japan). We also isolated ®broblast cell lines
(CF-1, CF-2, and CF-3) from long-term culture of single cell culture
from the epidermal sheets of three different donors as described
previously (Nakagawa et al, 1993; Iwagami et al, 1994).
Coculture of CD34+ HPC with cutaneous ®broblasts Three
milliliters of NDF-1, NDF-2, CF-1, CF-2, or CF-3 (1 3 105 cells per
ml) were seeded in either 60 3 15 mm style Petri dishes or six-well ¯at
bottom multiwell tissue culture plate (Becton Dickinson Labware,
Franklin Lakes, NJ). When these cells became con¯uent, they were
irradiated with 2000 rad by a Softex (Tokyo, Japan). Afterwards,
3 3 104 cells per ml of cord blood CD34+ HPC were added to these
®broblast cultures. Cultures were kept at 37°C in a 5% CO2 humidi®ed
condition. Every 6±7 d after culture, 200±300 ml of fresh complete
medium were added to the cultures. Cells were recovered by gentle
pipetting at 21±28 d of culture for analysis. In some experiments,
neutralizing mouse anti-M-CSF antibody (10 mg per ml) (R&D Systems,
Minneapolis, MN), neutralizing rat anti-GM-CSF antibody (5 mg per
ml) (PharMingen), or isotype-matched control antibodies (PharMingen)
was added to the culture.
Dividing chamber culture By using a six-well format cell culture
insert with a 0.4 mm pore-sized polyethylene terephthalate (PET) track-
etched membrane (Becton Dickinson Labware) in six-well ¯at bottom
multiwell tissue culture plates, CD34+ HPC were placed in the upper
chambers that were separated from the con¯uent culture of irradiated
CFCL at the bottom of the plates. The numbers of CD34+ HPC and
CFCL, and the volume of culture medium in the dividing chamber
culture were identical to those in the control coculture.
Culture with cytokines As control experiments, we cultured CD34+
HPC with a combination of GM-CSF (50 ng per ml), TNF-a (10 ng
per ml), and Flt3L (50 ng per ml) in the complete culture medium for
6 d according to the procedure described by Jaksits et al (1999), which
produced both CD1a+ E-cad+ BG+ Langerhans cells and
CD1a+ CD11b+ CD36+ FXIIIa+ E-cad± BG± non-Langerhans cell DC.
We also cultured CD34+ HPC with 50 ng per ml of GM-CSF or
100 ng per ml of M-CSF for 21 d. We changed one-half the volume of
culture medium every 4 d with fresh medium containing the same
concentration of GM-CSF or M-CSF. In some of the cultures with M-
CSF, we added anti-M-CSF antibody or irrelevant control antibody
(10 mg per ml) once every 4 d.
Flow cytometry To determine the surface phenotypes of cultured
CD34+ HPC, the cells harvested after culture were treated with a
combination of FITC-conjugated antibody (25 mg per ml) and PE-
conjugated antibody (25 mg per ml). For E-cad expression, the cells were
®rst incubated with anti-E-cad antibody or isotype-matched control
antibody, then blocked with mouse serum, and revealed by FITC-
conjugated anti-mouse immunoglobulins (Tago Immunologicals,
Camarillo, CA). After washing with phosphate-buffered saline
supplemented with 1% bovine serum albumin and 0.02% NaN3 (FACS
buffer), the cells were analyzed by FACScan using CellQuest software
(Becton Dickinson). Dead cells were gated out after staining with 0.5 mg
per ml of propidium iodide solution.
Table I. Effects of CFCL on the proliferation of CD34+ HPC and their differentiation into CD1a+ cells with or without
direct contacta























NDF-1 1 n.c. 5.9 5.0 58.3 n.c. 0.6 n.c. n.c.
NDF-1 2 9.0 3.4 1.9 40.8 n.c. n.c. n.c. n.c.
NDF-1 3 9.0 6.2 1.8 52.8 1.2 n.c. n.c. n.c.
NDF-1 4 10.5 1.0 0.7 53.2 9.0 0.8 0.6 95.8
NDF-1 5 24.0 0.2 0.2 70.4 21.6 0.2 0.2 88.0
NDF-2 6 33.6 0.7 0.5 83.4 5.4 1.6 0.3 91.0
NDF-2 7 15.0 8.5 6.2 35.2 n.c. 0.2 n.c. n.c.
NDF-2 8 18.0 2.1 1.5 47.9 6.0 n.c. n.c. n.c.
CF-2 1 27.0 28.0 7.5 57.6 n.c. n.c. n.c. n.c.
CF-3 1 30.0 28.7 13.1 54.4 n.c. n.c. n.c. n.c.
CF-3 2 16.5 32.7 16.8 51.9 4.8 4.9 1.6 82.3
CF-3 3 24.0 14.1 5.2 61.5 22.6 9.0 2.6 44.1
CF-3 4 21.0 23.6 9.5 48.5 3.0 17.7 1.6 63.8
CF-3 5 33.9 37.7 18.6 51.5 n.c. n.c. n.c. n.c.
Mean 6 SEM 20.1 6 2.4 13.8 6 3.6 6.3 6 1.6 54.9 6 3.2 9.2 6 2.9 4.4 6 2.2 1.2 6 0.4 77.5 6 8.1
GM-CSF, TNF-a, 1 21 5.8 4.9 84.9
and Flt3L 2 64 3.88 3.0 77.2
an.c. not counted. CD34+ HPC were cocultured with CFCL for 21 d. Then the cells were recovered, counted and analyzed by ¯ow cytometry. The increase in cell
number was expressed as the fold increases of the numbers of recovered cells after culture against the numbers of plated CD34+ cells.
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Confocal laser scanning microscopy Immunohistochemical analysis
of FXIIIa and Lag expression was performed on cytospin slides for
CD34+ HPC cocultured with CFCL and for those cultured with a
combination of GM-CSF, TNF-a, and Flt3L. The slides were at ®rst
®xed and permeabilized by Fix & Perm Cell Permeabilization Kit
(Caltag Laboratories, An Der Grub, Austria). After blocking with goat
serum, the slides were treated either with Lag or nonreactive mouse
IgG1 antibody followed by FITC-conjugated anti-mouse
immunoglobulins (Tago Immunologicals) or with anti-FXIIIa or anti-
FVIII antibody followed by FITC-conjugated anti-rabbit
immunoglobulins (Tago Immunologicals). The slides were mounted in
permaFluor (Lipshaw Immunon, Pittsburgh, PA) containing 0.5 mg
propidium iodide per ml, and observed under a confocal microscope
(Leica microscope and system GmbH, Wetzlar, Germany).
Stimulation with TGF-b1, TNF-a, or LPS CD34+ HPC were
harvested from the coculture and then stimulated in the complete culture
medium with 10 ng TGF-b1 per ml, 10 ng TNF-a per ml, or 10 ng
LPS per ml for 48 h.
Allogeneic T cell stimulation Peripheral blood mononuclear cells
were obtained by Ficoll Paque (Pharmacia) gradient centrifugation of
heparinized blood. These peripheral blood mononuclear cells were
treated with a pan T cell isolation kit (Miltenyi Biotec), according to the
manufacturer's protocol. These enriched T cells consisted of more than
95% CD3+ cells. T cells (2 3 105 cells per well) were cocultured in 96-
well ¯at-bottom microtiter plates with various numbers of cultured
CD34+ HPC. After 4 d of culture at 37°C in a 5% CO2 humidi®ed
atmosphere, the cells were pulsed with 5 mCi per ml of [3H]-thymidine
(Radiochemical Center, Amersham, U.K.) for the last 16 h of culture.
At the end of the culture period, the cells were transferred on to glass
®ber and [3H]-thymidine incorporation was measured using a liquid
scintillation counter. The results were expressed as the mean 6 SEM of
triplicate cultures. To decrease the background proliferation, cultured
CD34+ HPC were irradiated with 2000 rad with a Softex.
Enzyme-linked immunosorbent assay for GM-CSF and M-CSF
production by ®broblasts NDF-1, NDF-2, CF-1, CF-2, and CF-3
were cultured in complete medium. After the cells became con¯uent,
Figure 2. The coculture with CFCL induces
the differentiation of CD34+ HPC into
CD14+ monocytes and CD1a+ DC. CD34+
HPC were cultured alone in the complete
medium for 7 d, with various CFCL (CF-1, CF-
2, and NDF-1) without any exogenous cytokines
for 21 d, or without CFCL in the presence of
GM-CSF, TNF-a, and Flt3L for 10 d. After
culture, the cells were recovered and analyzed by
¯ow cytometry. These data are representative of
three independent experiments.
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the cultures were replaced with new complete medium and further
cultured for 1 wk. The recovered supernatants were measured for GM-
CSF and M-CSF by enzyme-linked immunosorbent assay kits obtained
from R&D Systems, using 96-well microtiter plates, according to the
manufacturer's instructions. The levels of GM-CSF and M-CSF were
calculated by using a standard curve obtained with recombinant
Figure 4. DC differentiated from CD34+
HPC by CFCL do not express BG-associated
antigen, Lag, but express FXIIIa. The cytospin
slides for CD34+ HPC cocultured with NDF-1
were examined for the expression of BG-
associated antigen, Lag (a) and FXIIIa (d). (b, e)
demonstrate DC stained with relevant control
antibodies for anti-Lag antibody and anti-FXIIIa
antibody, respectively. (c) shows DC differentiated
from CD34+ HPC cultured with a combination
of GM-CSF, TNF-a, and Flt3L stained with anti-
Lag antibody. Similar data were also obtained by
the coculture with other CFCL.
Figure 3. The coculture with CFCL induces the differentiation of CD34+ HPC into CD1a+ CD11b+ CD11c+ HLA-DR+ E-cad± DC.
CD34+ HPC were cultured with CF-3 without any exogenous cytokines for 21 d, and then the cells were analyzed by ¯ow cytometry. These data are
representative of four independent experiments.
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GM-CSF (from 0 to 1000 pg per ml) and M-CSF (from 0 to 1000 pg
per ml). The data were expressed the mean 6 SEM of triplicate
determinations.
RESULTS
CD34+ HPC differentiate into CD1a+ non-Langerhans cell
DC and CD14+ monocytes in the coculture with CFCL To
determine whether CFCL support the development of DC from
CD34+ HPC, CD34+ HPC were cocultured with irradiated
human CFCL. When CD34+ HPC were cultured alone in the
complete medium, most of them died within 7 d (Fig 1a). In
contrast, when they were cultured with CFCL without any
exogenous cytokines, the growth of both adherent and
nonadherent cells became recognizable within 7 d and they
continued growing for at least 1 mo (Fig 1b). When these
growing cells were recovered from the coculture with gentle
pipetting and further cultured without ®broblasts, they made small
aggregates of DC (Fig 1c). CD34+ HPC expanded 20.1 6 2.4-
fold in the coculture (n = 13) (Table I), whereas CD34+ HPC
cultured without CFCL in the presence of a combination of GM-
CSF (50 ng per ml), TNF-a (10 ng per ml), and Flt3L (50 ng per
ml) in the complete culture medium for 6 d expanded 21- and 64-
fold in two different experiments and produced aggregates of DC
(Fig 1g).
Immunophenotypic analysis of the cocultured cells (Fig 2)
revealed that they were composed of 54.9 6 3.2% CD14+ cells and
13.8 6 3.6% CD1a+ cells, in which 6.3 6 1.6% were
CD1a+ CD14± cells (Table I). In addition, 20±34% were HLA-
DR+ CD11c+ cells. There were no CD3+ or CD19+ cells. These
phenotypic characteristics were similar to those of CD34+ HPC
cultured with a combination of GM-CSF, TNF-a, and Flt3L,
which was reported to induce the differentiation of CD34+ HPC
into DC by Jaksits et al (1999), although the cocultured cells
contained more CD1a+ CD14+ cells than CD34+ HPC cultured
with a combination of cytokines. There was a signi®cant difference
in the ability to induce the differentiation of CD34+ HPC into
CD1a+ cells among the ®ve different CFCL. Namely, CF-3
induced the differentiation into CD1a more ef®ciently than NDF-1
(p = 0.01).
The coculture of CD34+ HPC with CFCL induced aggregates
of CD1a+ cells with DC morphology. Therefore, we clari®ed
further their phenotypic characteristics. In Fig 3, showing repre-
sentative data of four different cocultures with CF-3, it is
demonstrated that CD1a+ cells in the coculture, which were 50±
60% of CD14+ or 40±50% CD14±, expressed HLA-DR antigen,
but did not express E-cad, CD80, or CD86. Although we did not
perform double staining of anti-CD1a antibody with anti-CD11b
antibody or anti-CD11c antibody in this experiment, the data
showing that CD1a+ cells expressed HLA-DR, whereas most of
HLA-DR+ cells expressed CD11b or CD11c, suggested the
expression of CD11b and CD11c on CD1a+ cells. We observed
similar phenotypic characteristics in the cells cocultured with other
CFCL.
Next, we examined immunohistochemically the expression of
BG-associated antigen, Lag, and FXIIIa on CD34+ HPC
cocultured with CFCL. In Fig 4, it is shown that they contained
40% of FXIIIa+ cells, but no Lag+ cells. In contrast, CD34+ HPC
cultured with a combination of GM-CSF, TNF-a, and Flt3L
contained Lag+ cells. These phenotypic analyses suggested that
CFCL supported the differentiation of CD34+ HPC into
CD1a+ E-cad± Lag± FXIIIa+ CD11b+ CD11c+ HLA-DR+ cells,
which were reported as the phenotype of non-Langerhans cell
Figure 5. DC differentiated from CD34+
HPC by CFCL increase their CD86
expression by TNF-a. CD34+ HPC were
harvested from the coculture after 21 d and then
stimulated in the complete culture medium with
10 ng per ml TNF-a for 48 h. Their surface
expression of CD83 and CD86 on CD1a+ cells
was examined by ¯ow cytometry. These data are
representative of three independent experiments.
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DC by Caux et al (1996a), although the coculture with CFCL
produced signi®cant numbers of CD14+ CD1a+ cells.
The effects of cytokines on DC obtained from the coculture
system The coculture of CD34+ HPC with CFCL induced both
CD1a+ CD14± cells and CD1a+ CD14+ cells. Caux et al (1996a),
have reported that CD1a+ CD14+ cells are in the middle of
differentiation of CD14+ DC precursor subsets to CD1a+ CD14±
DC. In addition, none of the CD1a+ cells derived from CD34+
HPC cocultured with CFCL expressed CD80 or CD86. These data
suggested that DC obtained from the coculture were still immature.
Therefore, to examine whether these immature DC can be
maturated, the cells recovered from the cocultures were treated
with TNF-a. The treatment of the cells with TNF-a for 2 d
produced large aggregates of DC (Fig 1e) that expressed CD86 and
CD83 (Fig 5), suggesting the induction of DC maturation.
Moreover, to examine whether these immature DC acquire the
Langerhans cells phenotype, we cultured them with TGF-b1. We
found that the treatment of the cells with TGF-b1 did not induce
any signi®cant morphologic changes (Fig 1f), nor the expression of
E-cad or Lag (data not shown).
Antigen presentation by DC differentiated from the
coculture of CD34+ HPC with CFCL Next, we studied the
antigen-presenting function of these DC differentiated from
CD34+ HPC cocultured with CFCL. When they were cultured
with allogeneic T cells, they stimulated the proliferation of
allogeneic T cells in a concentration-dependent fashion (Fig 6).
Even at 1000 cells per well, these cultured CD34+ HPC containing
10% CD1a+ cells signi®cantly stimulated allogeneic T cells.
Preculture of these cells with LPS or TNF-a signi®cantly
augmented the proliferation.
Both M-CSF produced by CFCL and direct interaction
between CD34+ HPC and CFCL are required for the
maximum proliferation of CD34+ HPC As the coculture of
CD34+ HPC with CFCL supported the growth and differentiation
of CD34+ HPC into CD1a+ DC and CD14+ monocytes, we next
investigated whether direct contact of CD34+ HPC with CFCL
was required for the proliferation and differentiation of CD34+
HPC. Using dividing chambers separated with semipermeable
membranes, we cultured CD34+ HPC in the upper chamber and
CFCL in the lower chamber. This culture condition still supported
the growth of CD34+ HPC, but the magnitude of cell proliferation
was less than one-half of that of the coculture (Table I). Statistical
analysis using the Mann±Whitney U test indicated a signi®cant
difference in the growth of CD34+ cells between the coculture and
the culture using the dividing chamber (p < 0.01). When examined
under an inverted microscope (Fig 1d), most of the cells in the
upper chamber were adherent and macrophage-like in
morphology. Furthermore, by ¯ow cytometry, the percentage of
CD1a+ cells in the upper chamber was 4.4 6 2.2, which was
signi®cantly less than the 13.8 6 3.6 that was noted in the
coculture (p < 0.05) (Table I and Fig 7). These data suggested that
the direct contact of CD34+ HPC with CFCL was required for
Figure 7. Direct contact between CD34+
HPC and CFCL are required for their
optimal differentiation into CD1a+ DC.
Using dividing chambers separated with
semipermeable membranes, we cultured CD34+
HPC in the upper chamber and CF-3 in the
lower chamber. After 21 d of culture, the cells
were recovered and analyzed by ¯ow cytometry
for the expression of CD1a and CD14. Similar
data were also obtained by the coculture with
other CFCL. These data are representative of four
independent experiments.
Figure 6. DC differentiated from CD34+ HPC by CFCL are
potent antigen-presenting cells in allogeneic mixed lymphocyte
culture. Puri®ed CD3+ T cells (2 3 105 cells per well) were cocultured
in 96-well ¯at bottom microtiter plates with various numbers of CD34+
HPC cocultured with CF-3. After 4 d of culture at 37°C in a 5% CO2
humidi®ed atmosphere, the cells were pulsed with 5 mCi per ml of
[3H]thymidine during the last 16 h of culture. The mean 6 SEM from
three replicates were taken from each sample culture. To decrease the
background proliferation, cultured CD34+ HPC were irradiated with
2000 rad. In some experiments, cultured CD34+ HPC were
prestimulated with 10 ng per ml of LPS or TNF-a for 48 h before T
cell stimulation. These data are representative of four independent
experiments.
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their maximum proliferation and differentiation into CD1a+ cells,
although soluble factors also played a signi®cant part in these
processes. As there are several papers that reported the role of GM-
CSF and M-CSF for the growth or differentiation of DC (Caux et
al, 1992; Reid et al, 1992; Santiago-Schwarz et al, 1992; Takashima
et al, 1995; Kamps et al, 1999), we measured the production of
GM-CSF and M-CSF from CFCL (Fig 8). NDF-1, NDF-2, and
CF-1 produced low but detectable levels of GM-CSF, whereas
CF-2 or CF-3 did not produce it at all. On the other hand, all the
CFCL secreted a signi®cant amount of M-CSF. Among CFCL,
CF-3 produced more than two times more M-CSF than did the
other CFCL, which agreed well with the potent ability of CF-3 to
support CD34+ cell growth and differentiation. These data
suggested that M-CSF, but not GM-CSF, might be responsible
for the proliferation or the differentiation of CD34+ HPC. It was
further con®rmed by the experiment using anti-M-CSF antibody
(Fig 9). Namely, when we added anti-M-CSF antibody to the
coculture of CD34+ HPC with CF-3, anti-M-CSF antibody
partially but still signi®cantly suppressed the proliferation of CD34+
HPC. When we added 100 ng M-CSF per ml in the culture of
CD34+ HPC as a control, there occurred their signi®cant
proliferation, but the number of recovered cells was almost half
of that of the coculture with CF-3. In addition, in this culture, anti-
M-CSF antibody completely abrogated the proliferation of CD34+
cells.
M-CSF produced by CFCL induces CD1a+ DC from the
culture of CD34+ HPC As M-CSF produced by CFCL was
found to be at least partially responsible for the induction of CD34+
HPC proliferation by the coculture of CFCL, we examined the
role of M-CSF on the differentiation of CD34+ HPC into CD1a+
DC. When we added anti-M-CSF antibody, anti-GM-CSF
antibody, or irrelevant isotype control antibody to the culture of
CD34+ HPC with CF-3, only anti-M-CSF antibody completely
suppressed the differentiation of CD1a+ cells (Fig 10). Therefore,
we checked the effect of M-CSF on the culture of CD34+ HPC.
M-CSF could induce the cells showing phenotypes almost identical
with those of the cocultured cells from CD34+ HPC (Fig 10).
Namely, they induced CD1a+ CD14±, CD1a+ CD14+, or
CD1a± CD14+ cells. In contrast, GM-CSF only induced
CD1a+ CD14+ cells. In addition, the cells induced by M-CSF
were Lag±, but FXIIIa+.
DISCUSSION
So far, most of the studies on DC growth and differentiation have
been performed with in vitro culture systems using a various
combinations of cytokines. Recently, however, Regnier et al
(1997) have demonstrated that CD34+ HPC cultured on epidermis
that was reconstructed on dead de-epidermized cellular human
dermis produced CD1a+ HLA-DR+ BG+ Langerhans cells with-
out any exogenous cytokines. This study suggests that only a
microenvironment that is composed of keratinocytes can induce
the differentiation of HPC into Langerhans cells. In spite of this
observation, however, at least two questions remain unanswered.
The ®rst one is that, as their culture system did not contain any
dermal cell components, it is not clear whether a reconstituted skin
microenvironment with keratinocytes plus ®broblasts might induce
the differentiation of HPC into dermal DC in addition to
Langerhans cells. The second question is how this culture system
induced the differentiation of HPC into Langerhans cells. Namely,
this study did not address whether soluble factors secreted by the
reconstructed epidermis or the direct contact of CD34+ HPC to
some components of this three-dimensional culture mediated the
differentiation of HPC into Langerhans cells. In this study, we
could demonstrate that the simple coculture of CD34+ HPC with
cutaneous ®broblasts induced their differentiation into CD1a+ E-
cad± BG± but CD11b+ CD11c+ FXIIIa+ non-Langerhans cell
interstitial DC without any exogenous cytokines. Nestle et al
(1993) reported that dermal DC were composed of three different
subsets, FXIIIa+ CD1a+ non-Langerhans cell interstitial DC, and
two other unique populations that were FXIIIa+ CD1a± CD14±
cells and FXIIIa+ CD1a± CD14+ cells. Interestingly, at least
phenotypically, our culture system using cutaneous ®broblasts
could induce all of these three subsets of dermal DC. Moreover,
these three different components were recognizable even after
3 wk of culture. These data suggest that the dermis containing
numerous ®broblasts supplies the environment for the differenti-
ation of dermal DC. Our subsequent studies further elucidated that
the maximum growth for CD34+ HPC and their differentiation
into CD1a+ cells require both their direct contact with CFCL and
M-CSF produced by CFCL, whereas their differentiation into
CD1a+ E-cad± BG± FXIIIa+ CD11b+ CD11c+ non-Langerhans
cell DC was solely mediated by M-CSF.
It is well known that M-CSF is produced by a variety of cell
types, including ®broblasts, bone marrow stromal cells, T cells,
endothelial cells, hepatocytes, and that of monocyte/macrophage
lineage (Rambaldi et al, 1987; Praloran et al, 1990; Clinton et al,
Figure 8. The production of GM-CSF by CFCL does not
correlate with their ability to induce DC from CD34+ HPC.
NDF-1, NDF-2, CF-1, CF-2, and CF-3 were cultured in complete
medium. After the cells became con¯uent, the cultures were replaced
with new complete medium and further cultured for 1 wk. The
recovered supernatants were measured for GM-CSF and M-CSF by
enzyme-linked immunosorbent assay. The levels of GM-CSF and M-
CSF were calculated by using a standard curve obtained with
recombinant GM-CSF (from 0 to 1000 pg per ml) and M-CSF (from 0
to 1000 pg per ml). Data are representative of two independent
experiments, and reported as the mean 6 SEM of triplicate
determinations.
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1992; Tobler et al, 1992; Tsukui et al, 1992; Nakajima et al, 1994).
Therefore, it is reasonable to speculate that M-CSF affects the
differentiation of DC; however, there is a controversy about the
effects of M-CSF on DC growth and differentiation. Xu et al
(1995) succeeded in generating long-term DC lines (XS series)
from murine epidermis. To establish and maintain these cell lines,
M-CSF produced by their feeder cell lines, called NS lines, is
indispensable (Takashima et al, 1995). Furthermore, they demon-
strated that XS lines as well as epidermal Langerhans cells express
M-CSF receptor, and that M-CSF stimulated the proliferation of
XS lines. In addition, Kamps et al (1999) have demonstrated that
instead of GM-CSF, M-CSF also could induce DC in conjunction
with TNF-a and IL-4. Moreover, Dalloul et al (1999) demon-
strated that M-CSF augmented the production of DC from the
cultures of thymic CD34+ CD1a± cells with stem cell
factor+ Flt3± ligand+ IL-7. In contrast, Menetrier-Caux et al
(1998) reported the inhibitory effects of M-CSF or IL-6 produced
by tumor cells on DC differentiation from CD34+ HPC. In this
experiment, however, they always examined the effects of M-CSF
on DC differentiation in cultures containing GM-CSF and TNF-
a; they did not examine the effects of M-CSF alone on CD34+
HPC. This study demonstrated that both the coculture with CFCL
and the culture with M-CSF induced CD1a+ CD14± DC.
Interestingly, although we cultured CD34+ HPC for more than
3 wk in our experiments, these DC remained immature without
the expression of CD80, CD83, or CD86. Moreover, nearly half of
the CD1a+ cells were still CD14+. It suggested that M-CSF
induced DC, especially dermal DC, and kept them in an immature
state, although these immature DC could exhibit a potent antigen-
presenting function and be maturated by TNF-a stimulation.
Studies (Takahashi et al, 1993; Witmer-Pack et al, 1993;
Usuda et al, 1994) using op/op mice, which cannot produce
functional M-CSF, have demonstrated normal differentiation of
DC without M-CSF, although reduced density (Witmer-Pack et
al, 1993) and abnormal morphology (Takahashi et al, 1993) of
epidermal Langerhans cells were also reported. These data
mainly focused on epidermal Langerhans cells, however, but not
on dermal DC. Therefore, these studies still cannot answer the
question of whether M-CSF in¯uence the differentiation of
dermal DC in vivo.
On the other hand, the experiments using a dividing chamber in
this study also suggested the in¯uence of direct contact of CD34+
HPC with ®broblasts on their proliferation. As the integrins,
especially b1 integrin(s), were reported to be involved in the
regulation of HPC proliferation and differentiation (reviewed in
Coulombel et al, 1997), we speculated that the growth of HPC
supported by their direct contact with ®broblasts was mediated
through the interaction of b1 integrin(s) on CD34+ HPC with the
extracellular matrix produced by ®broblasts. Indeed, Staquet et al
(1997) have demonstrated that ®bronectin upregulated the in vitro
generation of DC from CD34+ HPC. When we added anti-b1
integrin antibody in this coculture system, however, we could not
detect any inhibitory effects on the proliferation of CD34+ cells or
their differentiation into CD1a+ cells (data not shown). So far, we
have been unable to ®nd out any candidates that cause the
proliferation and differentiation of CD34+ cells supported by their
direct contact with cutaneous ®broblasts.
We found a signi®cant difference in the ability of different
CFCL to induce CD1a+ DC. CF-3, which was obtained from
the long-term culture of single cells from epidermal sheets, was
much more ef®cient than the neonatal ®broblast cell lines.
Previous studies (Nakagawa et al, 1993; Aiba et al, 1994, 1995;
Iwagami et al, 1994) have reported that cutaneous ®broblast cell
lines obtained by this procedure have immunologic functions
distinct from those of the ®broblast cell lines obtained by
standard enzymatic treatment of the dermis. Namely, they
promote the growth of g/d T cell receptor-positive cells in
mice and produce various cytokines in addition to autologous T
cell activation after interferon-g treatment in humans. In this
study, although a considerable amount of M-CSF production
was demonstrated in the culture supernatants of all CFCL, CF-3
produced more than two times M-CSF than the two other
NDF lines, and induced signi®cantly more vigorous prolifer-
ation of CD34+ HPC than the other NDF lines. These data
again suggest the presence of heterogeneity in dermal ®broblasts
in terms of their immunologic functions. In this study, we
examined the effects of ®broblasts obtained from the skin.
Dermal DC belong to interstitial DC, which distribute in
various nonlymphoid tissues. Therefore, it was reasonable to
speculate that ®broblasts from other organs can induce DC from
CD34+ HPC in a coculture system. We cocultured CD34+
HPC with ®broblasts from the colon and lung. Expectedly,
these cultures could induce the proliferation of CD34+ HPC
and their differentiation into CD1a+ DC, although the
percentage of CD1a+ cells in them was about one-third of
that in the coculture with NDF-2 (data not shown).
Finally, despite the recent evidence presented for direct precur-
sors of Langerhans cells in the peripheral blood (Ito et al, 1999), we
did not obtain any information about the direct precursors of
dermal DC, Sallusto and Lanzavecchia (1994) and Romani et al
(1994) reported that even CD14 monocytes could be differentiated
into DC in a manner similar to dermal DC in a culture with GM-
CSF and IL-4. Our present data suggest that the environment that
allows the direct contact of HPC with cutaneous ®broblasts can
induce their differentiation into CD1a+ dermal DC. The next step
of our research is to determine or ®nd out the precursors of dermal
DC in the peripheral blood.
Figure 9. Anti-M-CSF antibody partially
suppresses the proliferation of CD34+ cells
cocultured with CF-3. We cultured CD34+
HPC with CF-3 or M-CSF (100 ng per ml) in
the presence or absence of anti-M-CSF antibody
or irrelevant antibody for 21 d. For the coculture
with CF-3, half the volume of the culture
medium was replaced with the same volume of
fresh medium every 7 d. For the culture with
GM-CSF or M-CSF, we changed one-half the
volume of culture medium every 4 d with fresh
medium containing the same concentration of
GM-CSF or M-CSF. In some of the cultures
with M-CSF, we added anti-M-CSF antibody or
irrelevant control antibody (10 mg per ml) every
4 d. After culture, we counted the number of
recovered cells. Data are reported as mean 6 SD
of three independent experiments. *p < 0.05 by
paired Student's t test.
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